IDiyas

For the Inventor, By the Inventor

Warren Township, NJ, United States of America

Jin-Jun Liu

USPTO Granted Patents = 24 

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 189(Granted Patents)


Location History:

  • Somerset County, NJ (US) (2003)
  • Warren Township, Somerset County, NJ (US) (2005)
  • Warren, NJ (US) (2000 - 2009)
  • Warren Township, NJ (US) (2002 - 2016)

Company Filing History:

goldMedal24 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 2000-2016

Loading Chart...
24 patents (USPTO):
1. 9371280 - Substituted pyrrolidine-2-carboxamides (2016-06-21),
2. 8354444 - Substituted pyrrolidine-2-carboxamides (2013-01-15),
3. 8288431 - Substituted spiroindolinones (2012-10-16),
4. 8017607 - N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions (2011-09-13),
5. 7851626 - 4,4,5,5, tetrasubstituted imidazolines (2010-12-14),
6. 7834179 - Spiroindolinone derivatives (2010-11-16),
7. 7723372 - Spiroindolinone derivatives (2010-05-25),
8. 7638548 - Spiroindolinone derivatives (2009-12-29),
9. 7553833 - 3,3-spiroindolinone derivatives (2009-06-30),
10. 7524840 - 7,8-disubstituted pyrazolobenzodiazepines (2009-04-28),
11. 7501428 - Quinazoline thiazolinones (2009-03-10),
12. 7495007 - Spiroindolinone derivatives (2009-02-24),
13. 7304074 - Substituted 1,5-naphthyridine azolinones (2007-12-04),
14. 7268231 - 1,5-Naphthyridine azolinone (2007-09-11),
15. 7115740 - Pyrimido compounds having antiproliferative activity (2006-10-03),

Title: Innovator Spotlight: Jin-Jun Liu and His Contributions to Anticancer Research

Introduction: Jin-Jun Liu is a renowned inventor based in Warren Township, NJ, whose innovative contributions in the field of pharmaceuticals have led to the awarding of 24 patents. His research focuses primarily on the development of novel compounds that can serve as effective anticancer agents, significantly impacting the healthcare industry.

Latest Patents: Among his most recent patents, Jin-Jun Liu has developed substituted pyrrolidine-2-carboxamides. These compounds encompass specific formulas where X, Y, Z, R, and R are intricately detailed. The compounds, including their enantiomers and pharmaceutically acceptable salts and esters, demonstrate promising utility as anticancer agents. The innovative nature of these compounds reflects Liu's dedication to advancing therapeutic options for cancer treatment.

Career Highlights: Jin-Jun Liu has built a notable career at Hoffmann-La Roche Inc., a leading biopharmaceutical company. His work has been characterized by a strong focus on chemical and pharmaceutical innovation, where he has significantly contributed to the development of new therapeutic agents targeting critical health issues.

Collaborations: Throughout his career, Jin-Jun Liu has collaborated with esteemed colleagues such as Zhuming Zhang and Kin-Chun Thomas Luk. These partnerships highlight the importance of teamwork in advancing research and innovation in the pharmaceutical sector, allowing for a diverse range of perspectives and expertise in the development of new drugs.

Conclusion: Jin-Jun Liu's impressive portfolio of 24 patents underscores his significant contributions to pharmaceutical research, particularly in the field of anticancer agents. His work not only exemplifies innovation in drug development but also embodies the collaborative spirit necessary for scientific progress. As he continues to push the boundaries of pharmaceutical sciences at Hoffmann-La Roche Inc., Liu remains a vital figure in the quest for effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…